Ortho Evra e-Resource

FDA Revises Ortho Evra Patch Label For Estrogen Warning

December 15, 2005

Last month the FDA announced it was revising the label for the Ortho Evra birth control patch due to the high levels of Estrogen women are exposed to when using the drug. The agency said women may be exposed to 60% more estrogen while on the patch than if they were taking a normal birth control pill.

Read the entire Ortho Evra FDA Q&A.;